This 100th edition marks a huge milestone for Research Review and for contributors over the last 10 years. We are grateful for the ongoing support of funders and for the many comments we receive after every edition. We hope it continues to support your educational needs and keeps everyone up to date with advancements.
For this 100th edition we feature:
Positive results for evolocumab in the FOURIER trial
Beta-blocker use in the elderly after AMI
US trends in the incidence of hospitalised AMI
Coffee, tea and cardiovascular events
Cangrelor vs glycoprotein IIb/IIIa inhibitors
Ezetimibe + statins in patients with ACS and multiple comorbidities
Heart failure with preserved ejection fraction has a better long-term prognosis
Atorvastatin is not cardioprotective during noncardiac surgery
Prognosis in heart failure patients with vs without diabetes
Low-dose aspirin is ineffective for primary prevention in diabetics
Please login below to download this issue (PDF)